| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.88B | +6.9% |
| Cost of Revenue | $3.02B | +5.9% |
| Gross Profit | $2.86B | +8.0% |
| R&D Expense | $517.7M | +9.3% |
| SG&A Expense | $418.2M | +0.0% |
| Operating Income | $1.34B | +11.1% |
| Interest Expense | $463.0M | -2.8% |
| Pre-tax Income | $893.7M | +4.2% |
| Income Tax | $132.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $567.1M | +31.2% |
| Accounts Receivable | $902.0M | +12.8% |
| Current Assets | $4.86B | +20.0% |
| Total Assets | $19.04B | +5.2% |
| Current Liabilities | $4.35B | +15.4% |
| Long-term Debt | $6.99B | +4.8% |
| Total Liabilities | $12.44B | +6.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.39B | +14.3% |
| Capital Expenditures | $61.4M | +8.5% |
| Investing Cash Flow | -$855.7M | -218.8% |
| Financing Cash Flow | -$152.3M | -121.4% |
| Free Cash Flow | $1.33B | +14.6% |
| -47.0% |
| Net Income | $760.5M | +25.3% |
| EPS (Basic) | $3.09 | +26.1% |
| EPS (Diluted) | $3.00 | +25.5% |
| Stockholders' Equity |
| $6.53B |
| +3.1% |